Sources | Names Used |
---|---|
GDSC1000 | MPS-1-IN-1 |
PharmacoGx | MPS-1-IN-1 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CACNA2D3 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-08 |
mRNA | CACNA2D4 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-08 |
mRNA | ACVR1B | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-08 |
mRNA | SGCE | GDSC1000 | pan-cancer | AAC | -0.2 | 4e-08 |
mRNA | FUT7 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-08 |
mRNA | GPLD1 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-08 |
mRNA | ERC2 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-08 |
mRNA | CD37 | GDSC1000 | pan-cancer | AAC | -0.23 | 5e-08 |
mRNA | FIGLA | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-08 |
mRNA | PFKFB3 | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-08 |